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RAMP1 und RAMP3 kontrollieren die Effekte von Amylin auf Futteraufnahme, 
Glukose und Energiehaushalt in männlichen und weiblichen Mäusen 
Bernd Coester, Sydney W Pence, Soraya Arrigoni, Christina N Boyle, Christelle Le 
Foll, Thomas A Lutz 
 
Amylin ist ein Peptid aus dem endokrinen Pankreas und nimmt eine Schlüsselrolle in 
der Kontrolle von Futteraufnahme und Energiehaushalt ein, wobei es mehrheitlich an 
drei Rezeptoren bindet (AMY 1-3). AMY 1-3 bestehen aus einem Calcitonin-
Rezeptor (CTR) und jeweils einem rezeptor-aktivität-modifizierenden Protein 
(RAMP1-3). In dieser Studie verwenden wir RAMP1, RAMP3 und RAMP1/3 globale 
knockout (KO) Mausmodelle um herauszufinden, wie sich das Fehlen einzelner oder 
beider Komponenten auf Futteraufnahme, Glukosehaushalt und Metabolismus 
auswirken. Von allen Mausmodellen mit fehlenden RAMPs hatten nur die RAMP1/3-
KO, die eine Diät mit erhöhtem Fettgehalt (HFD) erhalten hatten, ein erhöhtes 
Körpergewicht. Männliche Mäuse mit RAMP3 KO auf normaler Diät und RAMP1/3 
KO auf HFD hatten eine reduzierte Glukosetoleranz. Alle Mausmodelle wurden dann 
mit Amylin und Lachs-Calcitonin (sCT), ein Agonist für den Amylin-Rezeptor, 
behandelt, um deren Auswirkung auf die Futteraufnahme zu vergleichen. RAMP1/3 
KO waren nicht sensitiv auf beide Behandlungen, während RAMP3 KO nur auf sCT, 
und RAMP1 KO nur auf Amylin reagierten. Generell wogen weibliche Mäuse weniger 
als männliche, aber nur bei RAMP1 KO konnte man eine klare Trennung zwischen 
Geschlechtern bezüglich Futteraufnahme beobachten. Letzten Endes zeigt diese 
Studie, dass der RAMP1-Subtyp hauptsächlich am Fetthaushalt beteiligt ist, 
während der RAMP3-Subtyp für Glukosehauhalt und den anorektischen Effekt von 
Amylin verantwortlich ist. 
 
• Fettspeicherung und -verwertung 
• Amylin-induziertes c-Fos in AP 
• Glukosehaushalt 
• Anorektischer Effekt von Amylin 
• Amylin-induziertes c-Fos in AP 
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Amylin is a pancreatic peptide, which acts as a key controller of food intake and 
energy balance and predominately binds to three receptors (AMY 1–3). AMY 1–3 are 
composed of a calcitonin core receptor (CTR) and associated receptor-activity 
modifying proteins (RAMPs) 1–3. Using RAMP1, RAMP3 and RAMP1/3 global KO 
mice, this study aimed to determine whether the absence of one or two RAMP 
subunits affects food intake, glucose homeostasis and metabolism. Of all the RAMP-
deficient mice, only high-fat diet fed RAMP1/3 KO mice had increased body weight. 
Chow-fed RAMP3 KO and high-fat diet fed 1/3 KO male mice were glucose 
intolerant. Fat depots were increased in RAMP1 KO male mice. No difference in 
energy expenditure was observed but the respiratory exchange ratio (RER) was 
elevated in RAMP1/3 KO. WT and RAMP1, RAMP3, and RAMP1/3 KO male and 
female littermates were then assessed for their food intake response to an acute 
intraperitoneal injection of amylin or its receptor agonist, salmon calcitonin (sCT). 
RAMP1/3 KO were insensitive to both, while RAMP3 KO were responsive to sCT 
only and RAMP1 KO to amylin only. While female mice generally weighed less than 
male mice, only RAMP1 KO showed a clear sex difference in meal pattern and food 
intake tests. Ultimately, the results from this study provide evidence for a role of 
RAMP1 in mediation of fat utilization and a role for RAMP3 in glucose homeostasis 
and amylin’s anorectic effect. 
  
RAMP1 and RAMP3 Differentially Control Amylin’s Effects on Food
Intake, Glucose and Energy Balance in Male and Female Mice
Bernd Coester, y Sydney W. Pence y Soraya Arrigoni Christina N. Boyle, Christelle Le Foll *y and Thomas A. Lutz y
Institute of Veterinary Physiology, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland
Abstract—Amylin is a pancreatic peptide, which acts as a key controller of food intake and energy balance and
predominately binds to three receptors (AMY 1–3). AMY 1–3 are composed of a calcitonin core receptor (CTR)
and associated receptor-activity modifying proteins (RAMPs) 1–3. Using RAMP1, RAMP3 and RAMP1/3 global
KO mice, this study aimed to determine whether the absence of one or two RAMP subunits affects food intake,
glucose homeostasis and metabolism. Of all the RAMP-deficient mice, only high-fat diet fed RAMP1/3 KO mice
had increased body weight. Chow-fed RAMP3 KO and high-fat diet fed 1/3 KO male mice were glucose intolerant.
Fat depots were increased in RAMP1 KO male mice. No difference in energy expenditure was observed but the
respiratory exchange ratio (RER) was elevated in RAMP1/3 KO. RAMP1 and 1/3 KO male mice displayed an
increase in intermeal interval (IMI) and meal duration, whereas IMI was decreased in RAMP3 KO male and female
mice. WT and RAMP1, RAMP3, and RAMP1/3 KO male and female littermates were then assessed for their food
intake response to an acute intraperitoneal injection of amylin or its receptor agonist, salmon calcitonin (sCT).
RAMP1/3 KO were insensitive to both, while RAMP3 KO were responsive to sCT only and RAMP1 KO to amylin
only. While female mice generally weighed less than male mice, only RAMP1 KO showed a clear sex difference
in meal pattern and food intake tests. Lastly, a decrease in CTR fibers did not consistently correlate with a
decrease in amylin- induced c-Fos expression in the area postrema (AP). Ultimately, the results from this study
provide evidence for a role of RAMP1 in mediation of fat utilization and a role for RAMP3 in glucose homeostasis
and amylin’s anorectic effect.
This article is part of a Special Issue entitled SI: Neuroscience of Obesity. ! 2019 IBRO. Published by Elsevier Ltd. All rights
reserved.
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INTRODUCTION
Amylin is synthesized by pancreatic b-cells and is co-
released with insulin in response to food intake and
increasing glucose levels (Ogawa et al., 1990). The amy-
lin receptor (AMY) is composed of a core calcitonin recep-
tor (CTR) a or b (Hay et al., 2005; Lutz, 2012), a class B1
G-protein-coupled receptor (GPCR), which heterodimer-
izes with one or several receptor activity-modifying pro-
teins (RAMPs 1, 2, 3) (McLatchie et al., 1998; Qi et al.,
2008) to form AMY1-3. These components are expressed
in the area postrema (AP), nucleus of the solitary tract
(NTS), the lateral hypothalamic area, ventromedial
(VMN) and arcuate (ARC) hypothalamic nuclei, and the
ventral tegmental area (Hilton et al., 1995; Le Foll et al.,
2015; Mietlicki-Baase et al., 2013). In the AP, we have
found that most individual CTRa-positive neurons co-
express one or more RAMP subunit. In addition, the same
study showed that exogenous amylin acutely down-
regulated RAMP1 and RAMP3 mRNA levels, but not
CTR, suggesting a possible negative feedback mecha-
nism of amylin on components of its own receptor
(Liberini et al., 2016). Several studies have demonstrated
that the AP is the primary site for peripheral amylin’s sati-
ating effects (Lutz et al., 2001; Riediger et al., 2001;
Riediger et al., 2004), but the ventromedial hypothalamus
(VMH= ARC+ VMN) is also a direct target for amylin
signaling. We have shown that amylin can activate ERK
signaling in proopiomelanocortin (POMC) neurons of the
ARC, independent of an action in the AP, and that this
effect is blunted in RAMP1/3 KO mice (Lutz et al.,
2018). Moreover, amylin can synergize with leptin in the
https://doi.org/10.1016/j.neuroscience.2019.11.036
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VMN by enhancing leptin-induced p-STAT3 signaling (Le
Foll et al., 2015; Turek et al., 2010). Amylin signaling is
also essential for the normal development of axonal out-
growth from POMC and agouti-related peptide/neuropep-
tide Y (AgRP/NPY) neurons to the PVN during the
neonatal period; RAMP1/3 KO mice have significantly
decreased a-melanocyte-stimulating hormone (MSH)
and AgRP axonal fiber outgrowth from ARC to PVN
(Lutz et al., 2018). While amylin’s effect on POMC neu-
rons is direct, its effect on AgRP/NPY neurons seems to
be indirectly mediated by interleukin-6 (IL-6) (Larsen
et al., 2016; Le Foll et al., 2015).
In addition to amylin, RAMPs can bind other peptides
when combined with other GPCR (Barbash et al., 2017).
When associated to the calcitonin receptor-like receptor
(CLR), RAMPs form the adrenomedullin (AM) receptors
and can bind calcitonin-gene related peptide (CGRP)
and adrenomedullin (Hay et al., 2015; Hay et al., 2017).
When RAMP1 is combined to CLR it preferentially binds
to CGRP, while RAMP3/CLR binds AM and AM2. CGRP
and AM are known to be potent vasodilators (Hendrikse
et al., 2019). CGRP can also act centrally to modulate
neuronal activity and stimulation of CGRP-expressing
neurons in the lateral parabrachial nucleus reduces food
intake (Campos et al., 2016; Essner et al., 2017). Further,
CGRP is also able to interact with AMY1 (Simms et al.,
2018). Thus, the association of RAMPs with these GPCR
modulates signaling of several hormonal systems.
To determine the contribution of individual RAMPs to
whole-body energy balance and glucose homeostasis,
male and female mice globally deficient in RAMP1,
RAMP3 or both RAMP1 and 3 were metabolically
phenotyped. We next determined the specific role of
RAMP1 and RAMP3 in regulating amylin’s control of
food intake and activation of AP neurons. Given the fact
that amylin enhances leptin signaling in the VMH,
leptin’s action on food intake was also tested in these
KO mice. Experiments were performed in both male and
female KO mice, which enabled the analysis of sex as a
factor influencing RAMP-deficient phenotypes.
EXPERIMENTAL PROCEDURES
Animal husbandry and diet
All animals were maintained in a temperature-controlled
(21 ± 2 "C) room on a 12:12 h light/dark schedule with
lights off at 1000 h. Food and water were provided
ad libitum. Unless otherwise specified, the animals were
fed a standard chow diet (Diet 3436, Provimi Kliba AG,
Kaiseraugst, Switzerland; energy content: 3.15 kcal/g,
65.4% energy from carbohydrates, 12.3% from fat and
22.4% from protein as percent of total energy content).
RAMP1/3 double KO mice (background: 129S6/SvEv;
kindly donated by Kathleen Caron, Univ. North Carolina,
Chapel Hill, NC, USA) (Dackor et al., 2007) were bred
in our facility. WT mice were age matched and derived
from the RAMP3 +/! colony. RAMP3 +/! and RAMP1
+/! mice (background: 129S6/SvEv; kindly donated by
Kathleen Caron) (Dackor et al., 2007) were also bred in
our facility and WT and KO littermates were used for
our experiments. Animals were genotyped using the fol-
lowing primers: RAMP1 forward TCATGGGGACCTT-
TAGGTAAGC, RAMP1 reverse ACAGCAATCCTTCT
ACCTCAACAC, RAMP3 WT band is detected using R3-
1: GTGCTCAAGGGTTCTGTCTG and R3-10:
GACCTGGTTCATCTCTGGCTCC and RAMP3 null band
is detected using R3-10: GACCTGGTT-
CATCTCTGGCTCC and neo-60: GCTTCCTCTTG
CAAAACCACA (Dackor et al., 2007). The animals were
kept in an enriched environment with cardboard houses,
wood chip bedding, and nesting material. Mice were
maintained in group-housing conditions unless specified.
All procedures were approved by the Veterinary Office
of the Canton Zurich, Switzerland.
RAMP1/3 KO mice experiments (Overview of the
experimental groups depicted in Fig. 7)
Cohort 1: Group-housed 4 wk-old male WT (n= 8) and
male RAMP1/3 KO (n= 8) mice were fed chow diet for
4 wks. They were then single-housed and fed 45% high
fat diet (energy content: 4.71 kcal/g, 35% energy from
carbohydrates (17% sucrose), 45% from fat, 20% from
protein as percent of total energy content; D12451
Research Diet) for 7 wks. Weekly body weight and food
intake were measured starting 1 h before dark onset.
After each diet period, mice underwent an oral glucose
tolerance test (i.e at 8 and 15 wk-old). Mice were then
transferred to the indirect calorimetry cages
(Phenomaster TSE Systems, Bad Homburg, Germany)
and their energy expenditure and respiratory exchange
ratio were assessed; the animals were maintained on
45% HF diet for this period. Terminally, 17 wk-old mice
were euthanized with an overdose of pentobarbital
(100 mg/kg i.p.) and their body composition was
analyzed (CT scan, La Theta LCT-100; see below).
Cohort 2: 6 wk-old male and female WT (n= 12) and
RAMP1/3 KO (n= 13) mice were fed chow diet and were
individually housed in cages equipped with BioDAQ Food
Intake Monitors (Research Diet, New Brunswick, NJ,
USA) to continuously measure food intake and meal
patterns. After one week of habituation and stabilization
of the baseline food intake, mice were assessed after a
12 h fast during the light phase for their response to
amylin (i.p. 20, 100, 500 mg/kg, H-9475, Bachem,
Bubendorf, Switzerland) and salmon calcitonin (sCT, i.p.
10 mg/kg, 4033011.0001, Bachem) in a randomized
cross-over manner. Terminally, 12 wk-old mice were
injected at dark onset, after a 12 h fast in the light
phase, with vehicle or 50 lg/kg of amylin and
transcardially perfused (n= 6–7/group).
Cohort 3: 9 wk-old male WT (n= 7) and RAMP1/3 KO
(n= 7) male mice were fed chow diet and were
individually housed in the BioDAQ-equipped cages.
After one week of habituation and stabilization of the
baseline food intake, mice were tested after a 12 h fast
for their response to leptin (i.p. 5 mg/kg, Peprotech,
London, UK) or amylin + leptin (i.p. 50 mg/kg + 5 mg/
kg). Mice were then transferred into the indirect
calorimetry system and their energy expenditure and
respiratory exchange ratio were measured. Terminally,
13 wk-old mice were injected at dark onset, after a 12 h
fast, with vehicle or 50 lg/kg of amylin and perfused
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(n= 3–4/group). The body carcasses were kept for body
composition measurement.
RAMP3 KO mice experiments (See flowchart in Fig. 7)
Cohort 1: 16 wk-old male and female WT and RAMP3 KO
littermate mice were fed chow diet and were individually
housed in BioDAQ-equipped cages. (n= 7–11/group).
Mice were assessed for their response to amylin (i.p.
20, 100, 500 mg/kg) and sCT (i.p. 10 mg/kg). An OGTT
was performed at the end of the food intake study at 20
wks old. Terminally, the animals were injected with
vehicle (NaCl 0.9%) or 50 lg/kg of amylin and perfused
(n= 8/group).
Cohort 2: 12 wk-old male WT and RAMP3 KO
littermate mice were fed chow diet and were individually
housed in BioDAQ-equipped cages. (n= 8/group).
Similarly, mice were assessed for their response to
leptin and amylin + leptin. Mice underwent an OGTT at
16–18 wks old and were then transferred to the indirect
calorimetry cages and their energy expenditure and
respiratory exchange ratio were assessed. Terminally,
mice were euthanized with an overdose of pentobarbital
(100 mg/kg) and their body composition was analyzed
(n= 8/group).
RAMP1 KO mice experiments (See flowchart in Fig. 7)
Cohort 1: 14 wk-old male and 10 wk-old female WT and
RAMP1 KO littermate mice were fed chow diet and
were individually housed in the indirect calorimetry
system to continuously measure food intake, energy
expenditure and respiratory exchange ratio
(n= 8/group/sex). After one week of habituation and
stabilization of the baseline food intake, mice were
assessed for their response to amylin (i.p. 20, 100,
500 mg/kg) and sCT (i.p. 10 mg/kg) similar to the above
experiments. An OGTT was performed at the end of the
food intake study. Terminally, the animals were injected
with vehicle or 50 lg/kg of amylin and perfused
(n= 8/group/sex).
Cohort 2: 18 wk-old male and 14 wk-old female WT
and RAMP1 KO littermate mice were fed chow diet and
were individually housed in indirect calorimetry cages
(n= 8/group/sex). Mice were assessed after a 12 h fast
for their response to leptin. An OGTT was performed at
the end of the food intake study at 22 and 18 wks old
respectively. Terminally mice were euthanized with an
overdose of pentobarbital (100 mg/kg) and their body
composition was analyzed.
Assessment of food intake and meal patterns
Following 7 days of acclimation in the BioDAQ cages,
mice were fasted for 12 h during the light phase. At dark
onset (10:00 h), food was returned and baseline
refeeding was measured for the subsequent 24 h. Meal
pattern criteria were an intermeal interval (IMI) of 600 s
and a minimal meal size of 0.02 g (Duffy et al., 2018).
Meal patterns of the RAMP1 KO mice housed in the indi-
rect calorimetry cages were assessed using similar crite-
ria; however, the meal duration was smaller than for
RAMP1/3 and 3 KO mice housed in the BioDAQ cages
due to difference in hopper design.
Oral glucose tolerance test
Food was removed 2 h prior to lights off and mice were
gavaged at lights off, using an intra-gastric needle
(1 mm " 30 mm) with 2 g/kg of D-glucose. Blood was
sampled from the tail prior to gavage (0) and at 15, 30,
60, 90, and 120 min post-gavage for glucose
measurement (Glucometer: Breeze2, Bayer, Zurich,
Switzerland). The area under the curve from 0 min to
120 min was calculated from above baseline value
(0 min time-point). Additionally, baseline blood was
harvested after a 2 h fast, 2 days before the OGTT,
under isoflurane anaesthesia (2%) by puncturing the
sublingual vein. Blood was collected in 100 ll EDTA
tubes containing protease inhibitors (Sigma Aldrich
P2714, Buchs, Switzerland) centrifuged at 10,000 rpm
for 10 min and the plasma was stored at !80 "C until
further processing.
Blood analysis
Plasma insulin and leptin were measured in duplicates
using the mouse metabolic duplex kit (Reference
K15124C, Meso Scale Discovery MD, USA) following
the manufacturer’s instructions. The detection limits are:
leptin 43–100,000 pg/mL and insulin 15–50,000 pg/mL.
Indirect calorimetry
A 16-cage TSE PhenoMaster open circuit indirect
calorimetry system was used for the determination of
O2 consumption and CO2 production (TSE Systems;
Bad Homburg, Germany). The system was calibrated
using precision calibration gases prior to each run.
Room air was passed through each cage at a flow rate
of 0.41 L/min. Every 20 min, cage air was sampled
from each individual cage and analyzed for O2 and
CO2. From these values, energy expenditure (EE) and
respiratory exchange ratio (RER) were calculated
based on equations from Weir (Weir, 1949). To account
for differences in body weight and body mass composi-
tion, EE data were corrected for individual lean body
mass (LBM in g) and fat mass (FM in g) using the follow-
ing equation: LBM+ 0.2FM, as recommended by Even
and Nadkarni (Even and Nadkarni, 2012; Piattini et al.,
2019).
Measurement of body composition
Bodies of the RAMP1/3 KO were CT scanned using a La
Theta LCT-100 (Hitachi Aloka Medical Ltd, Steinhausen,
Switzerland). The mice were placed supine in the
plexiglass holder with an inner diameter of 48 mm. The
X-ray source tube voltage was set at 50 kV with 1 mA
current. The region between the vertebrae L1–L4 was
evaluated for lean and fat mass. LaTheta LCT-100
software automatically distinguishes between visceral
and subcutaneous fat; however, each image was
examined and corrected if assigned incorrectly.
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RAMP3 and RAMP1 KO were analyzed with the
Caliper Quantum Tx micro CT scanner (Perkin Elmer)
located at the Zurich Integrative Rodent Physiology core
facility (ZIRP, UZH) using the settings (50 kV, 160 mA,
60 mm field of view). Similar to the RAMP1/3 KO mice,
the region between L1 and L4 were evaluated using the
Analyze 12.0 Software (AnalyzeDirect Inc, KS, USA),
allowing subcutaneous and visceral fat mass, as well as
lean mass, to be distinguished. In addition to LBM
+ 0.2FM, the fat ratio was calculated (subcutaneous
+ visceral fat)/(subcutaneous + visceral fat + lean
mass).
Immunohistochemistry
Brain perfusion. Mice and their respective WT
littermates were fasted for 12 h and at dark onset
were injected with vehicle (NaCl 0.9%) or amylin (i.p.
50 lg/kg). 90 min post-injection, mice were anesthetized
(Pentobarbital 100 mg/kg, i.p.) and perfused for 1.5 min
with 0.1 M phosphate buffer followed by 4%
paraformaldehyde in 0.1 M phosphate buffer (PB-PFA,
pH 7.4) for 2.5 min. Brains were post-fixed overnight in
4% PB-PFA and cryoprotected overnight in 20%
sucrose-0.1 M PB. They were then frozen in hexane on
dry ice for 3 min and stored at !80 "C. Frozen caudal
hindbrains were cut at 25 lm in 4 series and were
mounted onto superfrost plus slides (Life Technologies
Europe, Zug, Switzerland). Slides were stored in
cryoprotectant (50% 0.02 M KPBS, 30% ethylene glycol,
20% glycerol) at !20 "C until staining for amylin-induced
c-Fos and CTR fibers immunohistofluorescence (IHF) in
the AP.
c-Fos IHF. Slide mounted sections were washed in
0.02 M KPBS before being blocked overnight with 5%
normal donkey serum (NDS), 0.4% Triton X-100 in
0.02 M KPBS at 4 "C. Single-label c-Fos IHF was
carried out using rabbit anti-c-Fos antibody (1:500;
2250, Cell Signaling Technologies, BioConcept,
Allschwil, Switzerland) and slides were incubated for
48 h at 4 "C. Slides were washed in 0.02 M KPBS 5
times for 5 min and incubated for 2 h with 488 donkey
anti-rabbit for 2 h (1:100, Jackson ImmunoResearch,
LubioScience, Luzern, Switzerland). Sections were then
counterstained with DAPI, and coverslipped using
Vectashield Hardset mounting medium (Vectorlabs,
Servion, Switzerland).
Calcitonin receptor IHF. Slide mounted sections were
washed in 0.1% PBST (0.1% Triton X-100 in 0.01 M PBS)
before being blocked for 90 min with 3% NDS, 0.3%
Triton X-100 in 0.01 M PBS. Slides were washed in
0.1% PBST and incubated for 48 h at 4 "C in rabbit anti-
CTR (1:1000, ab11042, Abcam, Cambridge, UK) in
0.3% PBST. Slides were washed in 0.01 M PBS and in
0.1% PBST. Secondary antibody (CY3 donkey anti-
rabbit 1:100 in 0.3% PBST, Jackson ImmunoResearch)
was then applied for 2 h (Duffy et al., 2018; Potes et al.,
2012). Finally, sections were washed in 0.01 M PBS,
counterstained with DAPI, and coverslipped using Vec-
tashield Hardset mounting medium.
Quantitative analysis of immunolabelled cells and
fibers. Cells expressing c-Fos in the AP were imaged
using an L2 Imager upright microscope (Zeiss,
Germany). Images containing AP were set to the same
threshold and c-Fos-positive neurons were counted
using ImageJ (NIH) to allow for quantification. Three
consecutive AP sections from bregma !7.31 to !7.55
(Paxinos and Franklin, 2012), as verified by the DAPI
counterstain, were used for quantification.
For the quantitative analysis of CTR fiber density,
three sections through the AP from animals of each
experimental group were acquired using a Zeiss SP8
confocal system equipped with a 20"/0.75 objective
(HD1 488, laser 2% with 10% gain, zoom 1, pinhole 1,
Z stack 21 lm, step of 1 lm). Slides were numerically
coded to obscure the treatment group. Image analysis
was performed using ImageJ analysis software (NIH) as
previously described (Lutz et al., 2018). Briefly, each
image plane was set to a threshold and binarized to iso-
late labelled fibers from the background and to compen-
sate for differences in fluorescence intensity. The
integrated intensity, which reflects the total number of pix-
els in the binarized image, was then calculated. This pro-
cedure was conducted for each image plane in the stack,
and the values for all of the image planes in a stack were
summed. The resulting value is an accurate index of the
density of the processes in the volume sampled. To
ensure similar imaging conditions, the same microscope
set-up (including objective, zoom, laser power, gain)
was used to acquire all images within the same experi-
ment. For representative images, images were equally
adjusted for brightness and contrast within the same
experiment.
Statistics
Statistical comparisons among variables were made by 1-
or 2-way ANOVA with repeated measure and by 3-way
ANOVA (factors: time, genotype and sex), as
appropriate, with multiple comparison post-hoc analysis.
Comparisons between control and treated groups were
assessed using t-test for nonparametric statistics
(GraphPad Prism, La Jolla, CA, USA). All data are
expressed as mean ± SEM.
RESULTS
Role of RAMP1 and 3 in regulating body weight, food
intake, body composition and glucose tolerance
Body weight, food intake, glucose tolerance and
plasma hormones on chow and 45% HF diet of male
RAMP1/3 KO mice (cohort 1). RAMP1/3 KO and WT
male mice gained the same amount of weight and ate
similar amounts of food on chow diet (Fig. 1A–C). After
4 wks on 45% HF diet, RAMP1/3 KO gained more
weight than WT mice and cumulative food intake started
to significantly differ at the sixth week on 45% HF diet
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(P< 0.01, Fig. 1A–C). Body composition analysis on
chow diet was not different between 13 wk-old WT and
RAMP1/3 KO mice (Fig. 2Q). After 7 weeks on 45% HF
diet, RAMP1/3 KO male mice exhibited higher visceral
(+53%, P< 0.05), subcutaneous (+40%, P< 0.001),
and total fat mass (+49%, P< 0.001, Fig. 2R) while
lean mass was not different from WT mice (Fig. 2R).
Fasted glucose levels were significantly higher in
RAMP1/3 KO male mice than in WT mice fed chow diet
(P< 0.05, Fig. 1F). The glucose profile during the
OGTT was not different between chow-fed WT and
RAMP1/3 KO, however, the RAMP1/3 KO area under
the curve (AUC, calculated from above baseline) was
lower than WT, mainly due to the fact that RAMP1/3 KO
mice had a higher baseline glucose value and that the
glucose levels only mildly increased after the glucose
load. On 45% HF diet, RAMP1/3 KO and WT male mice
had similar levels of fasted blood glucose (Fig. 1G).
However, after 7 weeks on 45% HF diet, RAMP1/3 KO
mice became glucose intolerant (P< 0.05, Fig. 1G)
with a 103% increase in AUC (P< 0.01, Fig. 1G). On
chow and 45% HF diet, baseline insulin levels were not
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Fig. 1. Body weight, OGTT and blood analysis of WT/RAMP1/3 KO on chow and 45% HF diet, WT vs. RAMP1/3 KO (cohort 1 and 3), RAMP3 KO
(cohort 1), and RAMP1 KO (cohort 1–2), on chow diet. Body weight (A, D, E), body weight gain (B), food intake (C), OGTT and AUC on chow diet
(F, H, I, J, K) and 45%HF diet (G) in 15 wk-old male WT and RAMP 1/3 KO mice after 4 wks on chow diet and 7 wks on 45%HF diet, 12 to 16 wk-old
WT and RAMP3 KO male (M) and female (F) mice, 6 to 17 wk-old WT and RAMP1 KO male and female mice. Baseline insulin and leptin
measurements were performed at the end of each diet period (L–O). Values are represented as mean ± SEM; n= 8/group for WT and RAMP1/3
KO, n= 8/group for male WT/RAMP3 KO, n= 7/group for female WT/RAMP3 KO and n= 8/group for male and female WT/RAMP1 KO.
Statistics: two-way ANOVA with repeated measure followed by post-hoc Sidak’s test or Student’s t-test. Factors: genotype (Gen) and time. Data
with differing superscript differ from each other at P< 0.05. *P< 0.05, **P< 0.01 WT vs. KO.
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different, while leptin levels in RAMP1/3 KO mice were
significantly increased compared to WT mice (P< 0.01,
Fig. 1L, M). Furthermore, RAMP1/3 KO mice exhibited
elevated leptin levels on 45% HF diet, compared to
chow, which corresponds with the increase in fat mass
in HF diet-fed RAMP1/3 KO mice (P< 0.001, Fig. 2R).
Body weight, glucose tolerance and plasma hormones
on chow diet of male and female RAMP3 KO and RAMP1
KO mice. RAMP3 KO and WT littermate mice displayed
the same body weight on chow diet; generally, male
mice displayed a higher body weight than female mice
(P< 0.0001, F(1, 44) = 21.60, Fig. 1D). RAMP3 KO
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Fig. 2. Energy expenditure, RER and body composition of male WT/RAMP1/3 KO, on chow (cohort 3) and 45% HF diet (cohort 1), WT/RAMP3 KO
(cohort 2), and WT/RAMP1 KO (cohort 1–2) on chow diet. 24 h Energy expenditure (EE in kJ/h normalized to LBM *0.2FM) (A, E, I, M) and
respiratory exchange ratio (RER) (C, G, K, O) were measured in ad libitum fed mice. EE (B, F, J, N) and RER (D, H, L, P) during the light and the
dark phase were averaged in ad libitum or after a 12 h fast followed by vehicle injection (i.p. NaCl 0.9%) in chow (A–D) and 45% HF diet (E–H) fed in
male WT and RAMP 1/3 KO mice, chow-fed male WT and RAMP3 KO mice (I–L), chow-fed male WT and RAMP1 KO mice (M–P). Body
composition was determined between lumbar vertebrae 1 and 4 (L1-L4) in all genotype (Q–T). Values are represented as mean ± SEM;
n= 8/group for WT and RAMP1/3 KO, WT/RAMP3 KO and WT/RAMP1 KO. Statistics: two-way ANOVA with repeated measure followed by post-
hoc Sidak’s test or Student’s t-test. Factors: genotype (Gen) and time. Data with differing superscript differ from each other at P< 0.05. *P < 0.05,
***P < 0.001 WT vs. KO.
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and WT mice showed no difference in lean and fat mass
(cohort 2; Fig. 2S). Male and female RAMP3 KO
displayed comparable fasted glucose levels compared
to their respective WT littermates (cohort 2; Fig. 1H, I).
Compared to WT mice, male RAMP3 KO mice
displayed delayed glucose clearance during the OGTT
and a higher AUC (cohort 2; P< 0.05, Fig. 1H),
suggesting that the male RAMP3 KO mice are glucose
intolerant. In contrast, an improvement in glucose
tolerance was observed in RAMP3 KO female mice
(Fig. 1I). Circulating levels of insulin and leptin were not
different between male or female RAMP3 KO and WT
littermates fed chow diet (Fig. 1N).
Both male and female RAMP1 KO mice displayed the
same body weight on chow diet as their WT littermates
(cohort 1–2; Fig. 1E); female mice were consistently
lighter than male mice (P< 0.0001, F(1, 37) = 43.72,
Fig. 1D). Contrary to RAMP3 KO mice, RAMP1 KO
male mice on chow diet had higher visceral fat
(P< 0.05), total fat mass (P< 0.05), and displayed a
higher fat ratio (P< 0.05) than their WT littermates
(cohort 1–2; Fig. 2T), but had similar leptin levels
(cohort 1–2; Fig. 1O). Body composition of the female
mice was not different between WT and RAMP1 KO
(Data not shown), despite elevated leptin levels in the
RAMP1 KO female mice (+131%, P< 0.01, Fig. 1O).
Similar to RAMP3 KO mice, fasted glucose levels were
not different in RAMP1 KO and WT mice (cohort 1–2;
Fig. 1J, K). WT and RAMP1 KO mice also displayed a
similar glucose profile during the OGTT (cohort 1–2;
Fig. 1J, K), however female mice had an improved
glucose tolerance compared to male mice (P< 0.0014,
F(1, 24) = 13.13, Fig. 1J, K), which is likely due to their
lower body weight. Baseline insulin levels were not
different across all groups (cohort 1–2; Fig. 1O).
Feeding behavior of male and female RAMP1/3 KO,
RAMP3 KO and RAMP1 KO mice
Male RAMP1/3 KO mice consumed 38% fewer meals in
24 h that were 51% longer in duration, and 116% larger
in size in the light phase compared to WT mice (cohort
2; P< 0.05, Table 1). The intermeal interval (IMI) was
also increased by 67% in the RAMP1/3 KO male mice
compared to WT (P< 0.05, Table 1). This suggests
that ad libitum-fed RAMP1/3 KO male mice feel less
satiated during a meal, but sated longer after a meal
than WT mice. Opposite to male mice, female WT and
RAMP1/3 KO ate the same amount of food during the
light and dark phases, with no differences in meal
number or meal size; only IMI was increased in both the
dark and light phase in RAMP1/3 KO females. Even
though some meal pattern parameters were significantly
different in male and not in female mice, no overall
difference between male and female RAMP1/3 KO was
detected during the 24-h time-period (P= 0.85, F(1,
78) = 0.0345). However, when taking into account all
food intake parameters, an interaction between time and
genotype was observed (P= 0.03, F(3,78) = 3.03).
On chow diet, ad libitum-fed WT and RAMP3 KO mice
showed no differences in 24-h food intake, meal number,
meal size or duration. In male RAMP3 KO mice, the
average 24-h IMI was decreased by 34 % compared to
WT, resulting from a decrease in the light phase (cohort
1; P< 0.05, Table 2). Female RAMP3 KO mice
displayed a significant decrease in total food intake,
meal size and IMI compared to WT mice, but only in the
light phase (cohort 1; P< 0.05, Table 2). Overall male
and female 24-h food intake pattern was different
(P< 0.01, F(1, 24) = 7.618) but no genotype effect
was detected (P= 0.59, F(1, 24) = 0.29). During the
light phase only, there was an overall difference
Fig. 2 (continued)
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between WT and RAMP3 KO meal pattern parameters
(P= 0.009, F(1, 24) = 7.983). The consistently
observed decrease in IMI suggests that male and
female RAMP3 KO mice experience less satiety than
WT mice.
Meal pattern analysis in RAMP1 KO mice (cohort 1;
Table 2) showed that male RAMP1 KO mice took longer
meals during the 24-h period (+41%, P< 0.05), which
primarily resulted from an increase in meal duration
during the dark phase (+54%, P< 0.05). 24-h IMI was
Table 1. Ad libitum food intake, meal number, meal size, meal duration and intermeal interval (IMI) for 24 h and during the light and dark phase in male
and female WT vs. RAMP1/3 KO mice (cohort 2). Values are represented as mean ± SEM; n = 6–7/group; *P < 0.05 WT vs. KO after an unpaired t-
test
24 h 12 h light phase 12 h dark phase
WT RAMP1/3 KO WT RAMP1/3 KO WT RAMP1/3 KO
Male
Total food intake (g) 4.61 ± 0.43 4.16 ± 0.39 1.04 ± 0.16 1.33 ± 0.34 3.35 ± 0.43 2.67 ± 0.56
Meal number 12.5 ± 0.75 7.75 ± 1.53* 4.17 ± 0.38 2.63 ± 0.52 7.08 ± 0.60 5.00 ± 0.51
Meal size 0.37 ± 0.03 0.58 ± 0.07 0.25 ± 0.03 0.54 ± 0.02* 0.56 ± 0.11 0.68 ± 0.24
Meal duration (Min) 40.8 ± 4.77 61.9 ± 17.6* 31 ± 2 39 ± 3 74.4 ± 17 96 ± 31*
IMI (Min) 83 ± 4 139 ± 18* 139 ± 19 236 ± 50* 46 ± 6 97 ± 20**
Female
Total food intake (g) 4.00 ± 0.45 3.80 ± 0.36 1.29 ± 0.33 1.31 ± 0.41 2.57 ± 0.19 2.47 ± 0.26
Meal number 10.6 ± 1.31 10.5 ± 1.65 3.83 ± 0.70 3.61 ± 0.72 6.33 ± 0.75 5.89 ± 0.98
Meal size 0.42 ± 0.05 0.41 ± 0.05 0.35 ± 0.08 0.32 ± 0.06 0.50 ± 0.08 0.53 ± 0.10
Meal duration (Min) 40.2 ± 5.69 56.3 ± 9.1 34 ± 7 51 ± 6 79 ± 19 85 ± 18
IMI (Min) 108 ± 10 118 ± 13 167 ± 33 224 ± 30* 61 ± 8 89 ± 12*
RAMP1/3 KO (24 h) -3 way-ANOVA Time P< 0.0001, Sex NS, Gen NS, Time " Sex NS, Time " Gen P= 0.03, Sex " Gen NS, Time " Sex " Gen NS.
Table 2. Ad libitum food intake, meal number, meal size, meal duration and intermeal interval (IMI) for 24 h and during the light and dark phase in WT
vs. RAMP3 KO male and female mice (cohort 2) and RAMP1 KO male and female mice (cohort 1). Values are represented as mean ± SEM; n = 6–
7/group (RAMP3) and n = 8/group (RAMP1); *P < 0.05 WT vs. KO after an unpaired t-test
24 h 12 h light phase 12 h dark phase
WT RAMP3 KO WT RAMP3 KO WT RAMP3 KO
Male
Total food intake (g) 5.51 ± 0.34 5.54 ± 0.59 0.60 ± 0.18 0.39 ± 0.06 4.90 ± 0.28 5.15 ± 0.62
Meal number 11.28 ± 1.15 12.14 ± 1.60 3.10 ± 0.46 3.08 ± 0.37 8.15 ± 0.85 9.07 ± 1.20
Meal size 0.46 ± 0.07 0.40 ± 0.06 0.17 ± 0.03 0.12 ± 0.02 0.76 ± 0.13 0.67 ± 0.13
Meal duration (Min) 38 ± 9 30 ± 3.80 10.5 ± 1.70 8.5 ± 0.67 66 ± 16 50 ± 5
IMI (Min) 121 ± 19 74 ± 12* 217 ± 35 137 ± 14* 43 ± 3 39 ± 2
Female
Total food intake (g) 5.04 ± 0.49 5.91 ± 0.66 0.70 ± 0.10 0.45 ± 0.10* 4.34 ± 0.40 5.46 ± 0.71
Meal number 11.56 ± 1.27 10.5 ± 0.74 3.57 ± 0.38 3.80 ± 0.65 8.00 ± 0.90 6.70 ± 0.20
Meal size 0.46 ± 0.08 0.49 ± 0.06 0.21 ± 0.06 0.12 ± 0.02* 0.72 ± 0.15 0.86 ± 0.12
Meal duration (Min) 41 ± 11 42 ± 3 11 ± 1.5 12.5 ± 2.2 71 ± 12 71 ± 4.5
IMI (Min) 133 ± 20 74 ± 8* 222 ± 35 123 ± 11* 45 ± 7 38 ± 3
WT RAMP1 KO WT RAMP1 KO WT RAMP1 KO
Male
Total food intake (g) 3.05 ± 0.41 2.92 ± 0.40 0.52 ± 0.09 0.37 ± 0.10* 2.53 ± 0.35 2.55 ± 0.34
Meal number 18 ± 2 14 ± 2 3.86 ± 0.65 2.63 ± 0.61 14.1 ± 0.87 12.1 ± 0.96
Meal size 0.16 ± 0.02 0.19 ± 0.03 0.14 ± 0.02 0.15 ± 0.02 0.17 ± 0.03 0.21 ± 0.03
Meal duration (Min) 1.86 ± 0.26 2.63 ± 0.43* 1.71 ± 0.50 2.14 ± 0.60 1.86 ± 0.32 2.88 ± 0.40*
IMI (Min) 71 ± 9.3 91.7 ± 12.8* 183 ± 31 239 ± 50 48.3 ± 6.60 69.6 ± 6.20*
Female
Total food intake (g) 2.47 ± 0.30 2.54 ± 0.32 0.36 ± 0.11 0.41 ± 0.06 2.11 ± 0.29 2.13 ± 0.28
Meal number 19.8 ± 2.95 19 ± 2.5 3.50 ± 0.78 4.38 ± 0.74 17.2 ± 1.51 15.9 ± 1.98
Meal size 0.12 ± 0.02 0.13 ± 0.02 0.10 ± 0.02 0.10 ± 0.02 0.13 ± 0.02 0.14 ± 0.02
Meal duration (Min) 2.13 ± 0.51 2.50 ± 0.39 1.00 ± 0.31 2.00 ± 0.52 2.13 ± 0.51 2.63 ± 0.43
IMI (Min) 67.3 ± 9.50 67.5 ± 8.8 165 ± 28 153 ± 28 49 ± 7.9 49 ± 6.33
RAMP3 KO (24 h) 3 way-ANOVA Time P< 0.0001, Sex P= 0.01, Gen P= 0.59, Time " Sex P < 0.0001, Time " Gen NS, Sex " Gen NS, Time " Sex " Gen NS.
RAMP1 KO (24 h) 3 way-ANOVA Time P< 0.0001, Sex P= 0.049, Gen NS, Time " Sex P< 0.0001, Time " Gen P= 0.008, Sex " Gen NS, Time " Sex " Gen
P= 0.008.
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also increased in male RAMP1KO mice (+30%,
P< 0.05) compared to WT mice. Female RAMP1 KO
showed no alteration in their meal patterns compared to
WT mice. However, male and female 24-h food intake
pattern was different (P= 0.04, F(1, 136) = 4.261) and
even though no genotype effect was detected
(P= 0.12, F(1, 136) = 2.393), an interaction among
time " sex " genotype was detected (P= 0.008, F(4,
136) = 3.545).
The meal pattern analysis of the three KO mice
models reveals that RAMP1/3 KO mice displayed
greater alterations in meal patterns, specifically a
decrease in meal number and meal duration and an
increase in IMI, than the single RAMP KO mice. A clear
sex-difference was detected in the single KO mice
model but not in RAMP1/3 KO mice.
Role of RAMP1 and 3 in regulating EE and RER
On chow diet, WT and RAMP1/3 KO mice displayed the
same EE (Fig. 2A, B) and RER (cohort 3; Fig. 2C, D)
under ad libitum conditions and during refeeding after a
12-h fast. However, during the light phase, RER was
elevated by 7% in ad libitum fed RAMP1/3 KO mice as
compared to WT mice (cohort 3; P< 0.05, Fig. 2D). On
45% HF diet, WT and RAMP1/3 KO mice displayed no
differences in EE under ad libitum conditions or during
refeeding after a 12 h fast (cohort 1; Fig. 2E, F),
whereas the RER of ad libitum fed RAMP1/3 KO mice
was increased during the dark and light phase by 4.5%
and 5%, respectively (cohort 1; P< 0.05, Fig. 2H). This
effect of increased RER in the dark and the light phase
was also present in the RAMP1/3 KO mice during the
refeeding phase after a 12-h fast (4.5% and 7%
respectively P< 0.05, Fig. 2H). Overall, the consistent
increase in RER suggests that RAMP1/3 KO mice
preferentially utilize carbohydrate over fat when fed
chow or 45% HF diet. The analysis of the EE and RER
in ad libitum fed mice showed no significant differences
between male WT and RAMP3 KO (cohort 2; Fig. 2I–L)
or between male WT and RAMP1 KO mice on chow
diet (cohort 1–2; Fig. 2M–P). Interestingly, peripheral
treatment with sCT significantly decreased RER in WT
mice, but not in RAMP1KO mice (P< 0.01 vs. vehicle;
Data not shown).
Thus, while the depletion of either RAMP1 or RAMP3
subunit did not affect EE or RER, the depletion of both
subunits in RAMP1/3 KO elevated the RER on chow
and 45% HF diet.
Amylin’s and salmon calcitonin’s effect on food
intake in male and female RAMP1/3 KO, RAMP3 KO
and RAMP1 KO mice
Increasing doses of amylin, after a 12-h fast, had a
significant effect on 2 h food intake in WT mice but
Table 3. Summary of effects of RAMP 1/3, 3 and 1 KO compared to WT mice
RAMP1/3 KO RAMP3 KO RAMP1 KO
Parameters
Body Weight Chow: =
HFD: +
= =
Body Composition Chow: =
HFD: + fat
= Male: + fat
Female: =
Food Intake Chow: =
HFD: +
= =



















Basal Insulin Chow: =
HFD: =
= =
Energy Expenditure Chow: =
HFD: =
= =
RER Chow: + in light
HFD: +
= =

















Leptin: =; Amylin/leptin: N/A
Sex difference
Amylin-induced c-Fos – = =
CTR – – =
Legend: +: increased compared to WT, –: decreased compared to WT, =: no change compared to WT, N/A: not analyzed.
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Fig. 3. Amylin- and sCT-induced anorexia test in chow-fed male and female WT vs. RAMP1/3 KO (cohort 2), RAMP3 KO (cohort 1), and RAMP1
KO (cohort 1) mice. Cumulative food intake in g or as a percent of vehicle (veh, NaCl 0.9%) in WT vs. RAMP1/3 KO mice (A, B, G, H), WT vs.
RAMP3 KO mice (C, D, I, J), WT vs. RAMP1 KO mice (E, F, K, L) after 2 hours of being injected with either vehicle or amylin (i.p. 20, 100, 500 mg/
kg). Mice were also tested for their response to the amylin receptor agonist, salmon calcitonin (sCT 10 mg/kg i.p.) and 2 h food intake was measured
in WT vs. RAMP1/3 KO mice (M, N, S, T), WT vs. RAMP3 KOmice (O, P, U, V), WT vs. RAMP1 KO mice (Q, R, W, X). Data are displayed in means
of absolute values (A–F and M–R) and relative to vehicle (G–L and S–X) ± SEM; n= 6–7/group for WT/RAMP1/3 KO, n= 5–6/group for WT/
RAMP3 KO, n= 8/group for WT/RAMP1 KO. Statistics: two-way ANOVA with repeated measure followed by post-hoc Sidak’s test. Factors:
genotype (Gen) and treatment. (A-F and M–R) Data with differing superscript differ from each other within the same genotype at P< 0.05. (G-L and
S-X) *P< 0.05 WT vs KO. *P< 0.05, **P< 0.01, ***P< 0.001.
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showed no effect on RAMP1/3 KO male or female mice;
these effects were however lost at the 4 h time point
(Figs. 3A, B; 4A, B). When expressed as percent of
vehicle, the amylin dose of 500 mg/kg had a stronger
effect on 4 h food intake in WT male mice than in
RAMP1/3 KO mice (P< 0.05, Fig. 4G). Overall, when
taking into account all amylin doses at 4 h in male and
female mice, a significant interaction genotype by
treatment was observed (P= 0.02, F(3, 54) = 3.347)
but no sex difference was observed (P= 0.09, F(1, 21)
= 3.125 Fig. 4A, B). sCT had a stronger anorectic
effect at 2 h and 4 h post injection in WT mice than in
RAMP1/3 KO male mice (P= 0.05, F(1, 18) = 4.188
Fig. 3M, P= 0.018, F(1, 18) = 6.654 Fig. 4M) and a
significant difference in genotype between WT and
RAMP1/3 KO was detected (P= 0.028, F(1, 18)
= 5.705, Fig. 4M). However, at 24 h, sCT tended to
have the same effect in WT and KO mice (P< 0.05,
data not shown). When expressed as a percent of
vehicle, no significant difference was found between WT
and RAMP1/3 KO mice (Figs. 3S, T, 4S, T). Similar to
male mice, female RAMP1/3 KO did not respond to
amylin at the 2 h time point (Fig. 3B, H), and no
significant effect of sCT on food intake was observed at
2 h and 4 h (Figs. 3N, T, 4N, T). Together, these data
showed that RAMP1/3 KO male and female mice are
insensitive to amylin’s effect on eating compared to WT
mice.
Increasing doses of amylin after a 12 h fast decreased
4 h food intake in a dose response manner in WT female
mice, but had no such effect in RAMP3 KO female mice
(cohort 1; P= 0.007, F(1,39) = 7.9 Fig. 4D). A
Fig. 3 (continued)
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significant main effect of genotype was observed in
female mice (P= 0.0052, F(1,39) = 8.746) Figs. 3D,
4D), however, no sex-difference was detected at 2 h or
4 h post-injection (P= 0.51, F(1,14) = 0.43). When
expressed as percent of baseline, 500 mg/kg of amylin
had a significantly stronger effect on 2 h and 4 h food
intake in WT than in RAMP3 KO female mice (cohort 1;
P< 0.05, Figs. 3J and 4J). sCT significantly decreased
food intake at 2 h and 4 h post-injection in WT mice and
RAMP3 KO mice (cohort 1; P< 0.05, Figs. 3P, 4O,
Fig. 4 (continued)
Fig. 4. Amylin- and sCT-induced anorexia test in chow-fed male and female WT vs. RAMP1/3 KO (cohort 2), RAMP3 KO (cohort 1), and RAMP1
KO (cohort 1) mice. Cumulative food intake in g or as a percent of vehicle (veh, NaCl 0.9%) in WT vs. RAMP1/3 KO mice (A, B, G, H), WT vs.
RAMP3 KO mice (C, D, I, J), WT vs. RAMP1 KO mice (E, F, K, L) after 4 hours of being injected with either vehicle or amylin (i.p. 20, 100, 500 mg/
kg). Mice were also tested for their response to the amylin receptor agonist, salmon calcitonin (sCT 10 mg/kg i.p.) and 4 h food intake was measured
in WT vs. RAMP1/3 KO mice (M, N, S, T), WT vs. RAMP3 KOmice (O, P, U, V), WT vs. RAMP1 KO mice (Q, R, W, X). Data are displayed in means
of absolute values (A–F and M–R) and relative to vehicle (G–L and S–X) ± SEM; n= 6–7/group for WT/RAMP1/3 KO, n= 5–6/group for WT/
RAMP3 KO, n= 8/group for WT/RAMP1 KO. Statistics: two-way ANOVA with repeated measure followed by post-hoc Sidak’s test. Factors:
genotype (Gen) and treatment. (A–F and M–R) Data with differing superscript differ from each other within the same genotype at P< 0.05. (G–L
and S–X) *P < 0.05 WT vs KO. *P< 0.05, **P< 0.01, ***P< 0.001.
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4P). sCT had a comparable effect in male and female
mice (P= 0.96 F(1,27) = 0.0002). Thus, while amylin
was not able to produce an anorectic effect in RAMP3
KO mice, sCT acted normally in male and female
RAMP3 KO mice.
In the RAMP1 cohort, amylin similarly decreased 4 h
food intake in male and female WT and RAMP1 KO
mice (cohort 1; treatment P< 0.001, F(3,41) = 6.77
Fig. 4E and P< 0.024, F(3,39) = 3.49 Fig. 4F). The
overall response to amylin injections was significantly
different between male and female RAMP1 KO mice
(P= 0.007, F(1,28) = 8.42 Fig. 4E, F). No genotype
difference regarding amylin’s anorectic response was
detected between WT and RAMP1 KO mice at either
2 h or 4 h. The anorectic response to sCT was not
different between WT and RAMP1 KO male mice 4 h
post-injection (cohort 1; treatment P= 0.004, F(1,13)
= 12.5, genotype P= 0.029, F(1,14) = 5.90 Fig. 4Q)
and a main treatment effect was detected in female WT
and RAMP1 KO mice (P= 0.006, F(1,13) = 10.4
Fig. 4R). A main effect of sex was detected in RAMP1
KO mice in response to sCT (P= 0.02, F(1,27)
= 5.877). These data indicate that both amylin and sCT
are able to produce an anorectic effect in RAMP1 KO
mice, suggesting that RAMP3, but not RAMP1, subunit
is necessary for amylin’s anorectic effect.
Leptin-induced anorexia in male and female mice
RAMP1/3 KO, RAMP3 KO and RAMP1 KO mice
Leptin injection in WT mice tended to decrease food
intake at 4 h as expected, whereas it had no effect in
RAMP1/3 KO mice (cohort 3; Treatment effect
P= 0.001, F(2, 34) = 8.071, Fig. 5A). The combination
of amylin and leptin induced a further reduction in food
intake at 4 h post-injection, but this only reached
statistical significance in the WT mice and not in
RAMP1/3 KO mice (P< 0.05, Fig. 5A). When
expressed as a percent of vehicle, the leptin and amylin
combination had a 56% stronger decrease on food
intake at 1 h in WT mice as compared to KO mice
(P< 0.05, Data not shown). Thus, while leptin or amylin
alone had no effect on RAMP1/3 KO mice, their
synergistic action on food intake was delayed,
suggesting that leptin signaling pathway may still be
functional in these mice.
In WT and RAMP3 KO male mice, leptin alone had no
effect on food intake at any time point (cohort 2; Fig. 5C).
Administration of amylin and leptin together decreased
food intake by approximately 50% in both WT and
RAMP3 KO male mice 4 h after injection (Treatment
effect P< 0.01 F(2, 45) = 7.178, Fig. 5D), however this
treatment only reduced food intake compared to vehicle
rather in WT male mice than in RAMP3KO male mice
(Fig. 5B). In female mice, no treatment effect was
detected in WT or RAMP3 KO mice at 4 h post injection
(Fig. 5E). When expressed as a percent of baseline,
leptin had a significantly stronger anorectic effect in WT
mice than in RAMP3 KO female mice (P< 0.05,
Fig. 5F). Overall, no sex-difference between WT and
RAMP3 KO mice was detected for their response to
leptin or leptin + amylin (P= 0.40 F(1, 26) = 0.7051).
Thus, the absence of RAMP3 seems to not interfere
with leptin signaling in male mice while female mice
seem to be unresponsive.
WT and RAMP1 KO mice presented an overall sex-
difference for their response to leptin (cohort 2;
P= 0.0025, F(1, 28) = 11.01). However, leptin did not
produce an anorectic effect at any time point (cohort 2;
Fig. 5G–J) regardless of sex or genotype. Unfortunately,
the combination of amylin and leptin was not assessed
in these mice.
Effect of amylin on c-Fos and CTR fiber density in the
AP
Amylin significantly increased the number of c-Fos
positive neurons in the AP of WT mice by 7-fold (cohort
2–3; P< 0.05, Fig. 6A, C) compared to saline control
mice while it had no effect in RAMP1/3 KO male mice.
CTR fiber density in the AP was also decreased by 80%
in the RAMP1/3 KO mice compared to WT male mice
(cohort 3; P< 0.05, Fig. 6B, C). This decrease in c-Fos
and CTR in RAMP1/3 KO may explain the absence of
an amylin effect on food intake (Fig. 4A, G). RAMP1/3
KO female mice were not assessed.
In contrast to the double KO mice, amylin significantly
increased the number of c-Fos positive neurons in the AP
of both male and female WT and RAMP3 KO mice by 14-
fold and 12-fold, respectively (cohort 1; P< 0.05, Fig. 6D,
F). Similarly, amylin induced a 6-fold increase in c-Fos in
male and female WT and RAMP1 KO mice (cohort 1–2;
P< 0.001, Fig. 6G, H). CTR fiber density in the AP,
however, was decreased by 72% and 55% in male and
female RAMP3 KO mice, respectively, compared to WT
mice (cohort 1; P< 0.05, Fig. 6E, F). In RAMP1 KO
mice, CTR fiber density in the AP was comparable to
their WT counterparts (cohort 1–2; Fig. 6H, I).
DISCUSSION
These studies were undertaken to assess the influence of
deficiency in RAMP1, RAMP3, or RAMP 1 and 3 on
whole-body energy homeostasis using global knockout
mice. RAMPs are a critical component of the amylin
receptor, they promote receptor specificity and enhance
amylin’s affinity to the CTR core (Christopoulos et al.,
1999). Therefore, this study was particularly focused on
whether amylin or its receptor agonist, sCT, preferentially
act on specific amylin receptor subtype to affect food
intake. By phenotyping these three different mouse mod-
els, we highlighted the role of the RAMP1 subunit as a
mediator of fat storage and utilization, while the RAMP3
subunit contributes to glucose homeostasis and amylin’s
anorectic effect. Finally, the presence of at least one
RAMP subunit (1 or 3) is both necessary and sufficient
for amylin-induced c-Fos in the AP, when CTR is present
(Table 3).
The combined depletion of RAMP1 and 3 did not
affect body weight in male or female mice maintained
on chow diet. However, RAMP1/3 KO male mice
maintained on 45% HF diet gained more weight and ate
more than WT male mice, resulting in higher fat mass
and leptin levels. Our data suggest that RAMP1
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deficiency, and not RAMP3, drives
this effect, as the male RAMP1 KO
mice also demonstrated increased
fat mass, while RAMP3 KO mice
did not. While female RAMP1 KO
mice showed no change in fat
mass, they exhibited increased
leptin levels compared to WT
mice. Despite the increased fat
mass in RAMP1 KO and HF diet-
fed RAMP1/3 KO, neither
genotype demonstrated a
compensatory increase in EE.
The RAMP1/3 KO mice did,
however, exhibit preferred
utilization of carbohydrates over
fat. Chronic central injection of
amylin was shown to decrease
RER, which indicates higher fat
utilization, in outbred male rats
(Wielinga et al., 2010); hence, the
lack of amylin signaling in the
RAMP1/3 KO mice could be the
cause of elevated RER. As with
the fat mass, RAMP1 appears
more critical for this effect on
RER; while baseline RER was sim-
ilar in WT and RAMP1KO, sCT
was unable to decrease RER in
RAMP1 KO compared to WT mice.
Thus, when fats are not properly
utilized, this could lead to the
excessive accumulation that was
observed in the RAMP 1/3 and 1
KOs, leading to the idea that
RAMP1 is necessary to promote
fat utilization. In agreement with
this, the overexpression of human
RAMP1 (hRAMP1) in neurons
induced a lean phenotype and
lower leptin levels due to higher
EE, increased oxygen consump-
tion, body temperature, and sym-
pathetic tone subverting brown
adipose tissue (BAT) in mice
(Fernandes-Santos et al., 2013).
Further, nestin/hRAMP1 trans-
genic mice displayed elevated
mRNA levels of peroxisome prolif-
erator–activated receptor c coacti-
vator 1a and uncoupling protein 1
and 3 in BAT, and these changes
were reversed by chronic blockade
of sympathetic nervous system sig-
naling (Zhang et al., 2011). In line
with these previous studies, our
results indicate that RAMP1 con-
tributes to fat utilization, potentially
Fig. 5. Leptin- and amylin + leptin-induced anorexia test in chow-fed male WT vs. RAMP1/3 KO
(cohort 3), male and female RAMP3 KO (cohort 2) and male and female RAMP1 KO (cohort 2) mice.
Cumulative food intake in g or as a percent of vehicle (veh, NaCl 0.9%) in WT vs. RAMP1/3 KO male
mice (A, B), WT vs. RAMP3 KO male and female mice (D–F), WT vs. RAMP1 KO male and female
mice (G–J) after 4 hours of being injected with either vehicle or leptin (i.p. 5 mg/kg) or amylin + leptin
(i.p. 50 mg/kg + 5 mg/kg). Data are displayed in means of absolute values (A, C, E, G, I) and relative
to vehicle (B, D, F, H, J) ± SEM; n= 8/group for WT/RAMP1/3 KO, n= 8/group for WT/RAMP3 KO,
n= 8/group for WT/RAMP1 KO. Statistics: two-way ANOVA with repeated measure followed by post-
hoc Sidak’s test. Factors: genotype (Gen) and treatment. Data with differing superscript differ from
each other within the same genotype at P < 0.05. *P < 0.05 WT vs KO. *P< 0.05, **P< 0.01,
***P < 0.001.
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through the activation of the sympathetic nervous system.
Further experiments testing sympathetic activity in
RAMP1 KO mice are required to validate this hypothesis.
In addition to increased weight gain and fat mass,
RAMP1/3 KO mice maintained on HF diet were glucose
intolerant. Male RAMP3 KO mice were also glucose
intolerant, despite displaying similar body weight and fat
mass to WT mice, suggesting that RAMP3 contributes
to the regulation of glucose homeostasis, independently
of changes in body weight or composition. Supporting
this finding, Liu et al. also described a tendency for
decreased glucose tolerance in female RAMP3 KO (Liu
et al., 2018). The fact that male and female RAMP1 KO
mice handled a glucose load similarly to WT mice, further
confirms the role of RAMP3, and not RAMP1, in glucose
control.
To further understand the role of RAMP1 and RAMP3
in influencing spontaneous food intake, detailed meal
pattern analyses were performed in chow-fed KO mice.
The increase in IMI and meal duration observed in
RAMP1 and 1/3 KO male mice, and increased meal
size in RAMP1/3 KO males, suggest that these mice
are more sated between meals while also displaying
delayed or decreased satiation. Decreased meal size is
a hallmark of amylin-induced satiation (Lutz et al., 1995;
Morley et al., 1997). Thus, the prolonged meals observed
in RAMP1 and RAMP1/3 KO mice suggests that amylin
acts to terminate meals via the
AMY1 receptor. CGRP also acts
in the brain to induce satiation
(Campos et al., 2016), and binds
to AMY1 and AM1, both of which
contain RAMP1 (Gingell et al.,
2019; Hay et al., 2015). Reduced
CGRP signaling in the RAMP1
KO mice could therefore also con-
tribute to the altered spontaneous
feeding pattern. Conversely, both
male and female RAMP3 KO mice
displayed a reduction in IMI, and
female RAMP3 KO mice actually
consumed less food and smaller
meals during the light phase. Such
a profile indicates enhanced diur-
nal satiation in RAMP3 KO mice.
One explanation for these para-
doxical results is that in absence
of RAMP3, the body compensates
by over-expressing RAMP1, which
would hypothetically enhance the
satiating effect of amylin or CGRP,
or perhaps RAMP2 whose effect
and role are not well studied.
Whether global deletion of a single
RAMP modifies the expression
pattern of other RAMPs has not
been investigated.
Because the altered meal
patterns in the RAMP-deficient
mice likely reflect changes in
endogenous amylin and CGRP
signaling, we more specifically
targeted the involvement of RAMP1 and 3 in amylin
signaling by characterizing the responsiveness of WT
and RAMP KO mice to exogenous amylin and sCT. WT
and RAMP1 KO mice responded in a similar anorectic
fashion to treatment with amylin and its receptor
agonist, sCT. Amylin failed to reduce food intake in
RAMP3 KO mice, while sCT had a similar anorectic
effect in WT and RAMP3 KO mice. Meanwhile, RAMP
1/3 KO mice did not respond to the anorectic effect of
amylin and were also unresponsive to the anorectic
effect of sCT in comparison to WT mice. These data
suggest that the RAMP3 receptor subunit is main
receptor mediating amylin’s acute anorectic response.
Indeed, previous studies hypothesized that RAMP3 may
be the primary amylin receptor for AP-mediated actions.
Earlier work from our group reported CTR+ neurons in
the AP preferentially expressed RAMP1 and RAMP3
together, as opposed to either one alone. However,
when CTR+ cells only expressed RAMP1 or 3, RAMP3
was the preferred accessory subunit (Barth et al., 2004;
Liberini et al., 2016). Further supporting the role of
RAMP3 in amylin’s anorectic action, a previous study
showed that the overexpression of RAMP1 did not alter
feeding behavior in chow-fed mice (Zhang et al., 2011),
however responsiveness to exogenous amylin was not
assessed.
Fig. 5 (continued)
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The AP is amylin’s and sCT’s primary site of action to
decrease food intake (Braegger et al., 2014; Lutz et al.,
2001), so we sought to determine if RAMP deficiency
changes how amylin activates AP neurons. To form a
functional amylin receptor both CTR and RAMP need to
be present (Hay et al., 2015). However unlike amylin,
sCT can bind to CTR in the absence of RAMPs (Hay
et al., 2005; Lutz et al., 2000). Amylin-induced c-Fos
was blunted in RAMP1/3 KO mice but not in single
RAMP3 and RAMP1 KO mice. Thus, it appears that at
least one RAMP subunit is needed for amylin to activate
AP neurons, as when both are depleted almost no c-
Fos signal was observed in AP neurons following treat-
ment with amylin. Interestingly, the CTR fiber density
was comparable between WT and RAMP1 KO mice,
while it was decreased in RAMP1/3 and single RAMP3
KO mouse models. While this decrease in CTR correlated
with the absence of the anorectic effect of amylin in
RAMP3 and RAMP1/3 KO mice, only the 1/3 KO mice
exhibited a decrease in amylin-induced c-Fos. We can
thus hypothesize that a minimum level of CTR is present
in RAMP3 KO mice and that this level is sufficient to form
AMY1 or AMY2 with the remaining RAMPs and activate c-
Fos, but it was not sufficient to produce an anorectic
effect. On the contrary, amylin was able to activate c-
Fos in the AP and decrease food intake in RAMP1 KO
mice, which displayed similar CTR fiber density as WT lit-
termates. This may indicate that both RAMP3 and CTR
need to be present for amylin to produce an anorectic
effect. Whether the presence of RAMP3 is implicated in
CTR transcription or affects CTR transport and integration
into the cell membrane remains to be determined. While
this report has focused on how RAMP deficiency alters
AP responsiveness to amylin, it is important to highlight
that RAMPs are located throughout the brain, providing
additional routes whereby RAMP deficiency could modify
energy balance. Brain nuclei such as ARC, VMN and VTA
have been shown to be responsive to amylin, express
Fig. 6. Amylin-induced c-Fos-positive neurons (A, D, G) and CTR density (B, E, H) were measured in the AP of WT vs. RAMP1/3 KO male mice
(cohort 2–3), RAMP3 KO (cohort 1) and RAMP1 KO (cohort 1) male and female mice 90 minutes after amylin (i.p. 50 mg/kg) or saline injection. (C, F,
I) 20X representative images of c-Fos and CTR IHC staining; AP brain sections were stained for c-Fos in green and counterstained with DAPI in
blue. CTR fibers are stained in red. Values are represented as mean ± SEM. n= 6–7/group for WT/RAMP1/3 KO, n= 8/group for WT/RAMP3
KO, n= 8/group for WT/RAMP1 KO. Statistics: two-way ANOVA with repeated measure followed by post-hoc Sidak’s test. Data with differing
superscript differ from each other at P< 0.05. t-test ****P< 0.0001 WT vs KO.
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RAMPs (Le Foll et al., 2015; Mietlicki-Baase et al., 2013),
and play a role in the control of food intake (Dunn-Meynell
et al., 2016; Mietlicki-Baase et al., 2015; Potes et al.,
2010). Notably, we have previously shown that in
RAMP1/3 KO mice, amylin-induced pERK was decreased
in POMC ARC neurons, and this effect was independent
of AP signaling (Lutz et al., 2018).
Our last aim was to determine if RAMP deficiency
alters leptin responsiveness. Early investigations into
the interaction of amylin and leptin focused on amylin’s
ability to restore or enhance leptin signaling in the ARC
and VMN (Le Foll et al., 2015; Lutz et al., 2018; Roth
et al., 2008; Turek et al., 2010). Our more recent work
revealed that functional leptin receptors seem to be nec-
essary for amylin signaling in the AP (Duffy et al.,
2018), suggesting a bi-directional interdependence of
these two hormones. RAMP1/3 KO mice were insensitive
to the effect of leptin and leptin + amylin. RAMP1 KO
mice demonstrated a tendency toward reduced leptin
sensitivity, while RAMP3 KO mice decreased their food
intake similarly to WT littermate when injected with lep-
tin + amylin. The consistent, blunted ability of leptin to
reduce food intake across RAMP KO models supports
the notion that amylin signaling promotes leptin sensitiv-
ity, however the present data cannot conclusively deci-
pher whether a specific RAMP is most critical for this
effect.
Given the fact that the prevalence of obesity is higher
in women (Hales et al., 2018), the interaction between the
signaling of estradiol and gut peptides is of great impor-
tance. While no sex differences were detected in
RAMP1/3 and RAMP3 KO mice, the RAMP1 KO differen-
tially affected male and female mice. Male RAMP1 KO
mice exhibited more fat mass, prolonged meals, and were
unresponsive to acute amylin effect on food intake, while
female RAMP1 KO mice were rarely different from their
WT controls. A limited number of studies have investi-
gated the influence of female sex hormones on the
expression of RAMPs. Female rats were shown to have
significantly lower baseline levels of RAMP1 mRNA in
the trigeminal ganglion than males (Stucky et al., 2011)
and treatment of estrogen-depleted ovariectomized
(OVX) female rats with exogenous estradiol resulted in
reduced expression of RAMPs 1, 2, and 3 in uterine tissue
(Thota et al., 2003). Whether females also have reduced
expression of RAMPs in the brain has not been deter-
mined, but it is plausible that the RAMP1 KO affected
female mice were less because female mice basally
express less RAMP1. An interaction between estradiol
and amylin has also been observed. Unlike most satiating
hormones, whose effects on food intake are enhanced by
estrogens, Trevaskis et al. showed that chronic amylin
infusion was more effective at reducing body weight, adi-
posity and food intake in estrogen-depleted OVX rats than
in control female rats or in OVX rats that received estra-
diol replacement therapy (Trevaskis et al., 2010).
Whether these differential affects resulted from differ-
ences in RAMP expression was not tested, but it is possi-
ble that enhanced amylin, and potentially also CGRP,
efficacy resulted from changes in RAMP1 expression in
the absence of estrogens.
To conclude, the results from our current study
provide evidence for a role of RAMP1 in the mediation
of fat utilization, while they suggest a role for RAMP3 in
Fig. 7. Flowchart summarizing the experimental procedures and cohorts for RAMP1/3 KO, RAMP3 KO and RAMP1 KO mice.
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glucose homeostasis. One of the RAMP is sufficient for
amylin-induced c-Fos in the AP but RAMP3 and CTR
need to be both present to produce amylin’s anorectic
effect. Whether the depletion of RAMPs alters other
non-amylin signaling pathways remains to be
determined as well.
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Mateos Melero and the Center for Microscopy and
Image Analysis, University of Zurich.
CLF, CNB and TAL designed the experiments. BC,
SWP, SA, CNB and CLF performed the experiments.
CLF, CNB and SWP wrote the manuscript. BC, SWP,
SA, CNB, CLF and TAL reviewed this manuscript.
Funding: SNF 31003A_156935 to TAL.
Declarations of interest: none.
REFERENCES
Barbash S, Lorenzen E, Persson T, Huber T, Sakmar TP (2017)
GPCRs globally coevolved with receptor activity-modifying
proteins, RAMPs. PNAS 114:12015–12020.
Barth SW, Riediger T, Lutz TA, Rechkemmer G (2004) Peripheral
amylin activates circumventricular organs expressing calcitonin
receptor a/b subtypes and receptor-activity modifying proteins in
the rat. Brain Res 997:97–102.
Braegger FE, Asarian L, Dahl K, Lutz TA, Boyle CN (2014) The role of
the area postrema in the anorectic effects of amylin and salmon
calcitonin: behavioral and neuronal phenotyping. Eur J Neurosci.
Campos CA, Bowen AJ, Schwartz MW, Palmiter RD (2016)
Parabrachial CGRP neurons control meal termination. Cell
Metab 23:811–820.
Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser
NJ, Main MJ, Foord SM, et al. (1999) Multiple amylin receptors
arise from receptor activity-modifying protein interaction with the
calcitonin receptor gene product. Mol Pharmacol 56:235–242.
Dackor R, Fritz-Six K, Smithies O, Caron K (2007) Receptor activity-
modifying proteins 2 and 3 have distinct physiological functions
from embryogenesis to old age. J Biol Chem 282:18094–18099.
Duffy S, Lutz TA, Boyle CN (2018) Rodent models of leptin receptor
deficiency are less sensitive to amylin. Am J Physiol Regul Integr
Comp Physiol 315:R856–R865.
Dunn-Meynell AA, Le Foll C, Johnson MD, Lutz TA, Hayes MR, Levin
BE (2016) Endogenous VMH amylin signaling is required for full
leptin signaling and protection from diet-induced obesity. Am J
Physiol Regul Integr Comp Physiol 310:R355–365.
Essner RA, Smith AG, Jamnik AA, Ryba AR, Trutner ZD, Carter ME
(2017) AgRP neurons can increase food intake during conditions
of appetite suppression and inhibit anorexigenic parabrachial
neurons. J Neurosci 37:8678–8687.
Even PC, Nadkarni NA (2012) Indirect calorimetry in laboratory mice
and rats: principles, practical considerations, interpretation and
perspectives. Am J Physiol Regul Integr Comp Physiol 303:
R459–476.
Fernandes-Santos C, Zhang Z, Morgan DA, Guo DF, Russo AF,
Rahmouni K (2013) Amylin acts in the central nervous system to
increase sympathetic nerve activity. Endocrinology
154:2481–2488.
Gingell JJ, Hendrikse ER, Hay DL (2019) New insights into the
regulation of CGRP-family receptors. Trends Pharmacol Sci
40:71–83.
Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL (2018)
Trends in obesity and severe obesity prevalence in US youth and
adults by sex and age, 2007–2008 to 2015–2016. JAMA
319:1723–1725.
Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD (2015) Amylin:
pharmacology, physiology, and clinical potential. Pharmacol Rev
67:564–600.
Hay DL, Christopoulos G, Christopoulos A, Poyner DR, Sexton PM
(2005) Pharmacological discrimination of calcitonin receptor:
receptor activity-modifying protein complexes. Mol Pharmacol
67:1655–1665.
Hay DL, Garelja ML, Poyner DR, Walker CS (2017) Update on the
pharmacology of calcitonin/CGRP family of peptides: IUPHAR
Review 25. Br J Pharmacol.
Hendrikse ER, Bower RL, Hay DL, Walker CS (2019) Molecular
studies of CGRP and the CGRP family of peptides in the central
nervous system. Cephalalgia 39:403–419.
Hilton JM, Chai SY, Sexton PM (1995) In vitro autoradiographic
localization of the calcitonin receptor isoforms, C1a and C1b, in
rat brain. Neuroscience 69:1223–1237.
Larsen L, Le Foll C, Dunn-Meynell AA, Levin BE (2016) IL-6
ameliorates defective leptin sensitivity in DIO ventromedial
hypothalamic nucleus neurons. Am J Physiol Regul integr Comp
Physiol: ajpregu 00258:02016.
Le Foll C, Johnson MD, Dunn-Meynell AA, Boyle CN, Lutz TA, Levin
BE (2015) Amylin-induced central IL-6 production enhances
ventromedial hypothalamic leptin signaling. Diabetes
64:1621–1631.
Liberini CG, Boyle CN, Cifani C, Venniro M, Hope BT, Lutz TA (2016)
Amylin receptor components and the leptin receptor are co-
expressed in single rat area postrema neurons. Eur J Neurosci
43:653–661.
Liu T, Kamiyoshi A, Tanaka M, Iida S, Sakurai T, Ichikawa-Shindo Y,
Kawate H, Hirabayashi K, et al. (2018) RAMP3 deficiency
enhances postmenopausal obesity and metabolic disorders.
Peptides 110:10–18.
Lutz TA (2012) Effects of amylin on eating and adiposity. In:
Handbook of experimental pharmacology. p. 231–250.
Lutz TA, Coester B, Whiting L, Dunn-Meynell AA, Boyle CN, Bouret
SG, Levin BE, Le Foll C (2018) Amylin selectively signals onto
POMC neurons in the arcuate nucleus of the hypothalamus.
Diabetes 67:805–817.
Lutz TA, Geary N, Szabady MM, Del Prete E, Scharrer E (1995)
Amylin decreases meal size in rats. Physiol Behav 58:1197–1202.
Lutz TA, Mollet A, Rushing PA, Riediger T, Scharrer E (2001) The
anorectic effect of a chronic peripheral infusion of amylin is
abolished in area postrema/nucleus of the solitary tract (AP/NTS)
lesioned rats. Int J Obesity Related Metab Disord 25:1005–1011.
Lutz TA, Tschudy S, Rushing PA, Scharrer E (2000) Amylin receptors
mediate the anorectic action of salmon calcitonin (sCT). Peptides
21:233–238.
McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N,
Solari R, Lee MG, et al. (1998) RAMPs regulate the transport and
ligand specificity of the calcitonin-receptor-like receptor. Nature
393:333–339.
Mietlicki-Baase EG, Olivos DR, Jeffrey BA, Hayes MR (2015)
Cooperative interaction between leptin and amylin signaling in
the ventral tegmental area for the control of food intake. Am J
Physiol Endocrinol Metabol 308:E1116–1122.
Mietlicki-Baase EG, Rupprecht LE, Olivos DR, Zimmer DJ, Alter MD,
Pierce RC, Schmidt HD, Hayes MR (2013) Amylin receptor
signaling in the ventral tegmental area is physiologically relevant
for the control of food intake. Neuropsychopharmacology
38:1685–1697.
Morley JE, Suarez MD, Mattamal M, Flood JF (1997) Amylin and food
intake in mice: effects on motivation to eat and mechanism of
action. Pharmacol Biochem Behav 56:123–129.
B. Coester et al. / Neuroscience xxx (2020) xxx–xxx 19
Please cite this article in press as: Coester B et al. RAMP1 and RAMP3 Differentially Control Amylin’s Effects on Food Intake, Glucose and Energy Balance in Male and Female Mice. Neuroscience (2020), https://doi.org/
10.1016/j.neuroscience.2019.11.036
Ogawa A, Harris V, McCorkle SK, Unger RH, Luskey KL (1990)
Amylin secretion from the rat pancreas and its selective loss after
streptozotocin treatment. J Clin Investig 85:973–976.
Paxinos G, Franklin K (2012) Paxinos and Franklin’s the mouse brain
in stereotaxic coordinates. 4th Edition. Academic Press.
Piattini F, Le Foll C, Kisielow J, Rosenwald E, Nielsen P, Lutz T,
Schneider C, Kopf M (2019) A spontaneous leptin receptor point
mutation causes obesity and differentially affects leptin signaling
in hypothalamic nuclei resulting in metabolic dysfunctions distinct
from db/db mice. Metab Mol.
Potes CS, Boyle CN, Wookey PJ, Riediger T, Lutz TA (2012)
Involvement of the extracellular signal-regulated kinase 1/2
signaling pathway in amylin’s eating inhibitory effect. Am J
Physiol, Reg Integ Comp Phyiol 302:R340–351.
Potes CS, Lutz TA, Riediger T (2010) Identification of central
projections from amylin-activated neurons to the lateral
hypothalamus. Brain Res 1334:31–44.
Qi T, Christopoulos G, Bailey RJ, Christopoulos A, Sexton PM, Hay
DL (2008) Identification of N-terminal receptor activity-modifying
protein residues important for calcitonin gene-related peptide,
adrenomedullin, and amylin receptor function. Mol Pharmacol
74:1059–1071.
Riediger T, Schmid HA, Lutz T, Simon E (2001) Amylin potently
activates AP neurons possibly via formation of the excitatory
second messenger cGMP. Am J Physiol Regul Integr Comp
Physiol 281:R1833–1843.
Riediger T, Zuend D, Becskei C, Lutz TA (2004) The anorectic
hormone amylin contributes to feeding-related changes of
neuronal activity in key structures of the gut-brain axis. Am J
Physiol Regul Integr Comp Physiol 286:R114–122.
Roth JD, Roland BL, Cole RL, Trevaskis JL, Weyer C, Koda JE,
Anderson CM, Parkes DG, et al. (2008) Leptin responsiveness
restored by amylin agonism in diet-induced obesity: evidence
from nonclinical and clinical studies. PNAS 105:7257–7262.
Simms J, Routledge S, Uddin R, Poyner D (2018) The structure of the
CGRP and related receptors. Handb Exp Pharmacol.
Stucky NL, Gregory E, Winter MK, He YY, Hamilton ES, McCarson
KE, Berman NE (2011) Sex differences in behavior and
expression of CGRP-related genes in a rodent model of chronic
migraine. Headache 51:674–692.
Thota C, Gangula PR, Dong YL, Yallampalli C (2003) Changes in the
expression of calcitonin receptor-like receptor, receptor activity-
modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus
during pregnancy, labor, and by steroid hormone treatments. Biol
Reprod 69:1432–1437.
Trevaskis JL, Turek VF, Wittmer C, Griffin PS, Wilson JK, Reynolds
JM, Zhao Y, Mack CM, et al. (2010) Enhanced amylin-mediated
body weight loss in estradiol-deficient diet-induced obese rats.
Endocrinology 151:5657–5668.
Turek VF, Trevaskis JL, Levin BE, Dunn-Meynell AA, Irani B, Gu G,
Wittmer C, Griffin PS, et al. (2010) Mechanisms of amylin/leptin
synergy in rodent models. Endocrinology 151:143–152.
Weir JB (1949) New methods for calculating metabolic rate with
special reference to protein metabolism. J Physiol 109:1–9.
Wielinga PY, Lowenstein C, Muff S, Munz M, Woods SC, Lutz TA
(2010) Central amylin acts as an adiposity signal to control body
weight and energy expenditure. Physiol Behav 101:45–52.
Zhang Z, Liu X, Morgan DA, Kuburas A, Thedens DR, Russo AF,
Rahmouni K (2011) Neuronal receptor activity-modifying protein 1
promotes energy expenditure in mice. Diabetes 60:1063–1071.
(Received 12 June 2019, Accepted 25 November 2019)
(Available online xxxx)
20 B. Coester et al. / Neuroscience xxx (2020) xxx–xxx





Der Autor dankt Christelle Le Foll, die als direkte Aufsichtsperson exzellente Arbeit geleistet hat und ein 
gutes Klima für die Forschungsarbeit generiert. 
 
Weiter ist den Co-Autoren Sydney Pence, Soraya Arrigoni und Christina Boyle zu danken, die ihrerseits 
Zeit und Arbeit in diese Studie investiert haben. 
 
Ein besonderer Dank gilt auch Thomas Lutz, der als Referent für diese Arbeit die Zielgebung, 
Infrastruktur und enge Begleitung der Forschungstätigkeit garantiert hat. 
Curriculum Vitae 
Bernd Coester  
Geburtsdatum: 12.04.1990  
Geburtsort: St. Gallen  
Nationalität: CH  
Heimatort: Zürich ZH  
07/1998 - 06/2005 Grundstufe [Primarschule, Glarus, CH] 
07/2003 - 06/2005 Oberstufe [Sekundarschule, Rapperswil, CH] 
07/2005 - 06/2009 Matura [Kantonsschule Ausserschwyz, Pfäffikon SZ, CH] 
 
07/2009 Höchster Schulabschluss [Matura, Kantonsschule 
Ausserschwyz, Pfäffikon SZ, CH] 
  
09/2010 – 08/2016 Studium [Veterinärmedizin, UZH, Zürich, CH] 
  
30.12.2016 Abschlussprüfung vet. med. [UZH, Zürich, CH] 
  
05/2017 – 02/2018 Anfertigung der Dissertation  
 unter Leitung von Christelle Le Foll, PhD 
 am Institut für Veterinärphysiologie 
 der Vetsuisse-Fakultät Universität Zürich 




05/2017 – Anstellung als Doktorand (60%),  
parallel Mitarbeiter Kleintierklinik (Stundenlohn) 
UZH, Zürich, CH 
  
  
  
  
  
  
  
 
